Aprea Therapeutics
APRE
APRE
41 hedge funds and large institutions have $10.4M invested in Aprea Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
59% less capital invested
Capital invested by funds: $25.6M → $10.4M (-$15.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holding in Top 10
–
Calls
$507K
Puts
$255K
Top Buyers
| 1 | +$1.25M | |
| 2 | +$809K | |
| 3 | +$405K | |
| 4 |
PP
PDT Partners
New York
|
+$157K |
| 5 |
VF
Virtu Financial
New York
|
+$120K |
Top Sellers
| 1 | -$6.44M | |
| 2 | -$3.55M | |
| 3 | -$385K | |
| 4 |
BlackRock
New York
|
-$351K |
| 5 |
Goldman Sachs
New York
|
-$345K |